Autoimmune Diabetes Associated With Pembrolizumab: A Review of Published Case Reports

The utility of immunotherapy, such as pembrolizumab, is becoming essential in the treatment of certain cancers. Pembrolizumab works through binding of programmed cell death 1 receptor that blocks the binding of the programmed cell death ligand 1 and is commonly used in non-small cell lung cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Anmol, Makadia, Bhaktidevi, Karwadia, Tejas, Bajwa, Ravneet, Hossain, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862076/
https://www.ncbi.nlm.nih.gov/pubmed/29581809
http://dx.doi.org/10.14740/wjon1085w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862076/
https://www.ncbi.nlm.nih.gov/pubmed/29581809
http://dx.doi.org/10.14740/wjon1085w

Ejemplares similares